[1]
La, N.T. et al. 2026. STUDY ON CLINICAL AND PARACLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES OF OVERACTIVE BLADDER WITH MIRABEGRON AT CAN THO UNIVERSITY OF MEDICINE AND PHARMACY HOSPITAL IN 2025 – 2026. Cantho Journal of Medicine and Pharmacy. 101 (Aug. 2026), 333–339. DOI:https://doi.org/10.58490/ctjump.2026i101.4732.